← Leaderboards
Julie Anne Saugstad
Emanuel Hospital And Health Center
$11,632,637
Attributed
$13,328,220
Total exposure
12
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.4M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,328,220 · 12
By mechanism
R01$6,319,072 · 5
RF1$3,429,850 · 1
UH3$1,222,405 · 1
R21$1,102,416 · 3
UH2$793,119 · 1
R03$461,358 · 1
Top collaborators
- Joseph F Quinn7 shared
- Halina Offner3 shared
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposIschemiaGene ExpressionMicrornasMolecularBrainNeuronsCause Of DeathPre-ClinicalAstrocytesResponseBrain InjuriesProteinsCellsGenesRegulationCell DeathMild Cognitive ImpairmentCerebrospinal FluidLiving DonorsDementiaBiological MarkersClinical ResearchMemory Loss
Grant awards (35)
Human Cerebrospinal Fluid Extracellular Vesicles: Utility as Disease Specific Biomarkers and Impact on Alzheimer's Disease Pathology$748,595
R01 · FY2025 · AG · contact PI
Human Cerebrospinal Fluid Extracellular Vesicles: Utility as Disease Specific Biomarkers and Impact on Alzheimer's Disease Pathology$721,871
R01 · FY2024 · AG · contact PI
Human Cerebrospinal Fluid Extracellular Vesicles: Utility as Disease Specific Biomarkers and Impact on Alzheimer's Disease Pathology$737,653
R01 · FY2023 · AG · contact PI
Establishing MicroRNA Biomarkers for Diagnosing Alzheimer's Disease & Predicting Progression$3,429,850
RF1 · FY2019 · AG · contact PI
Clinical Utility of MicroRNAs as Diagnostic Biomarkers of Alzheimer's Disease$525,094
UH3 · FY2016 · TR · contact PI
Sex differences in brain inflammation in experimental stroke$447,717
R01 · FY2016 · NS
Optimization and Normalization Studies for Individual CSF Samples$72,967
UH3 · FY2016 · TR · contact PI
Clinical Utility of MicroRNAs as Diagnostic Biomarkers of Alzheimer's Disease$525,094
UH3 · FY2015 · TR · contact PI
Sex differences in brain inflammation in experimental stroke$460,203
R01 · FY2015 · NS
Characterization of Extracellular Vesicles in Human CSF as Biomarkers for Disease$99,250
UH3 · FY2015 · TR · contact PI
Sex differences in brain inflammation in experimental stroke$467,723
R01 · FY2014 · NS
Clinical Utility of MicroRNAs as Diagnostic Biomarkers of Alzheimer's Disease$319,860
UH2 · FY2014 · TR · contact PI
MicroRNA-Mediated Translation Initiation Arrest In Ischemic Brain$193,482
R21 · FY2014 · NS · contact PI
Optimization and Normalization Studies for CSF as a Biomarker$77,000
UH2 · FY2014 · TR · contact PI
Clinical Utility of MicroRNAs as Diagnostic Biomarkers of Alzheimer's Disease$396,259
UH2 · FY2013 · TR · contact PI
MicroRNA-Mediated Translation Initiation Arrest In Ischemic Brain$236,877
R21 · FY2013 · NS · contact PI
Role for MicroRNAs in Ischemic Tolerance$301,840
R01 · FY2012 · NS · contact PI
Role for MicroRNAs in Ischemic Tolerance$288,023
R01 · FY2011 · NS · contact PI
Role for MicroRNAs in Ischemic Tolerance$11,858
R01 · FY2011 · NS · contact PI
Role for MicroRNAs in Ischemic Tolerance$306,000
R01 · FY2010 · NS · contact PI
Neuroprotection by Novel Regulators of mGluR Signaling$304,773
R01 · FY2009 · NS · contact PI
Neuroprotection by Novel Regulators of mGluR Signaling$304,773
R01 · FY2008 · NS · contact PI
Neuroprotection by Novel Regulators of mGluR Signaling$304,773
R01 · FY2007 · NS · contact PI
Role of MicroRNAs in Ischemic Tolerance$203,182
R21 · FY2007 · NS · contact PI
Neuroprotection by Novel Regulators of mGluR Signaling$313,875
R01 · FY2006 · NS · contact PI
Role of MicroRNAs in Ischemic Tolerance$174,375
R21 · FY2006 · NS · contact PI
Role of Acid-Sensing Ion Channels in Glaucoma$151,358
R03 · FY2006 · EY · contact PI
Role of Acid-Sensing Ion Channels in Glaucoma$155,000
R03 · FY2005 · EY
Extracellular Modulation of Metabotropic GluRs$147,250
R21 · FY2005 · MH
Role of Acid-Sensing Ion Channels in Glaucoma$155,000
R03 · FY2004 · EY
Extracellular Modulation of Metabotropic GluRs$147,250
R21 · FY2004 · MH
REGULATION OF METABOTROPIC GLUTAMATE RECEPTOR RESPONSES$199,839
R01 · FY2002 · MH
REGULATION OF METABOTROPIC GLUTAMATE RECEPTOR RESPONSES$194,022
R01 · FY2001 · MH
REGULATION OF METABOTROPIC GLUTAMATE RECEPTOR RESPONSES$154,839
R01 · FY2000 · MH
REGULATION OF METABOTROPIC GLUTAMATE RECEPTOR RESPONSES$50,695
R01 · FY2000 · MH